News | Page 26 | Graduate School of Medical Sciences

How The Nose Knows

Dr. Jonathan Victor is part of a team of researchers that last fall received a $6.4 million grant from the National Science Foundation aimed at uncovering the universal algorithms at work in the nervous system when animals use olfaction to navigate. An understanding of this neural circuitry could shed light on the human brain — and spur the development of technology to replicate the services that animals provide, thus keeping highly trained and often valuable animals out of dangerous...

NYC Cornell Graduate STEM Programs Open House 2016 RSVP

Saturday, October 8, 2016
10:00 AM – 2:00 PM
Belfer Research Building, Room 302 A-D
413 East 69th Street
New York, NY 10021

RSVP here

Three research institutions collaborate to host conference aimed at increasing diversity in science and medicine

Asst. Dean Elizabeth Wilson-Anstey

The 6th annual SPARC Jr. conference took place on July 25 at Memorial Sloan Kettering Cancer Center’s Rockefeller Research Laboratories Auditorium. SPARC, which stands for Achieving Successful and Productive Academic Research Careers, was launched in 2010 in direct response to the National Institute of Health’s call for a vigilant and expedient response to the underrepresentation of women and racial/ethnic minority investigators in academic research.

...

Bench to Bedside Initiative Entrepreneurship Kickoff + Networking Evening

Come meet aspiring entrepreneurs, inventors, scientists, clinicians, engineers and business professionals. Network with future teammates for our December Pitch Day!

Keynote Renier Brentjens, MD, PhD, Director, Cellular Therapeutics, MSKCC; Scientific Co-Founder of Juno Therapeutics (JUNO).

Featuring three BBI alumni startups:

Frank Borchetta, JD, Founder and CEO, Repairogen.

Kevin O'Rourke, MD, PhD candidate, Co-Founder, York Avenue Diagnostics.

Kate Rochlin,...

12th Annual Tri-Institutional Chemical Biology Symposium

12th Annual Tri-Institutional Chemical Biology Symposium
Wednesday, August 17, 2016
9 am – 5:30 pm
Zuckerman Research Building 105

Please visit http://chembio.triiprograms.org/symposium to register.

Jacob Litke & Michaelyn Lux
Co-Chairs
12th Annual TPCB Symposium

Precision Cancer Test Validated for Clinical Usage

A powerful next-generation genome-sequencing test developed at Weill Cornell Medicine can detect mutations that guide precision cancer treatment with over 95 percent accuracy, according to new research. The scientists say their findings, published July 20 in NPJ Genomic Medicine, validate the test, called Weill Cornell Medicine EXaCT-1, and demonstrate its feasibility in a clinical setting.

Dr. Olivier Elemento

Developed by Weill Cornell Medicine's Englander...

Metabolic protein linked to cancer and autoimmunity

Scientists in the lab of Lewis Cantley, Ph.D., director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine and NewYork-Presbyterian, found that a little gene with a long name – type 2 phosphatidylinositol-5-phosphate 4-kinase gamma (PIP4K2C) and its associated protein PI5P4Kγ- plays a role in the regulation of the immune system.

“This suggests that drugs that inhibit PIP4K2C function could be useful to enhance cancer immunotherapy,” said first author Hyeseok Shim,...

BBI Matches Inventors with Business Professionals

On May 24 the Bench to Bedside Initiative (BBI), together with Hacking Health NYC and gyro:human, hosted its inaugural Commercializing Life Science matchmaking event. The purpose of the event was to help inventors form successful teams around their patents by connecting them with talented business professionals outside of their respective fields with complimentary backgrounds. Ultimately, the hope is that these teams will form successful business enterprises and solve some...

We Are Weill Cornell Medicine : Dr. Randy Longman

Video of We Are Weill Cornell Medicine : Dr. Randy Longman

For gastroenterologist Dr. Randy Longman, having the greatest effect on his patients’ lives means searching for new strategies to treat – or even cure – their disease. As a physician-scientist at Weill Cornell Medicine, he possesses a unique insight into the integrative patient care encouraged and nurtured by the institution.

New Gene Therapy Protects Against Peanut Allergy

Dr. Ronald Crystal

A new gene therapy developed by scientists at Weill Cornell Medicine could eventually prevent the life-threatening effects of peanut allergy with just a single dose, according to a new pre-clinical study.

Peanuts are the most common food that induces fatal or near-fatal reactions in those who are allergic to them, yet preventive treatment is limited. In their study, published June 29 in the Journal of Allergy and Clinical Immunology, Weill...